Monthly Meetings of Previous Term

Monthly Meetings of Previous Term

Pharma Delegates conducts its meetings at noon on the third Wednesday of each month at the Tokyo American Club. Speakers have included Ministry officials, industry leaders in Japan and from overseas, science and technology experts, R&D executives, physicians, hospital pharmacists, HR specialists, CRO experts, academics, market researchers, industry analysts, economists, wholesalers and other entrepreneurs. Pharma Delegates conducts its meetings at noon on the third Wednesday of each month at the Tokyo American Club. Speakers have included Ministry officials, industry leaders in Japan and from overseas, science and technology experts, R&D executives, physicians, hospital pharmacists, HR specialists, CRO experts, academics, market researchers, industry analysts, economists, wholesalers and other entrepreneurs.

YEAR DATE Title and Speaker
2019 Sep. 18 “Initiative for the Sustainable Medicine”
  Taro Ueno, M.D., Ph.D., CEO, SUSMED, Inc
2019 Oct. 16 “Reaping the benefits of biotech: A two way street”
  Mr. BT Slingsby, M.D., PH.D., M.P.H. , Founder & Managing ,Partner, Catalys Pacific, LLC
2019 Nov. 15

Off-Site Seminar at Nippondaira Hotel

Main Theme
“ HTA – Understanding the current status & its implications for the Japanese pharma industry“

“Introduction to cost-effectiveness evaluation system in Japan (Japanese HTA) ”
   Speaker: Dr. Makoto Kobayashi, Ph.D., M.Eng., Director and COO, CRECON Medical Assessment Inc.

“Overview of HTA Activities from the Corporate Perspective - Based on the Experience from Pilot Program”
   Speaker: Mr. Shinya Ohno, HTA group of External Affairs, Chugai

“1) Lessons from Regional HTA and 2) the use of PROs”
   Speaker: Mr. Bruce Crawford, MA, MPH, Vice President, Real World & Late Phase, Syneos Health

“Options and impact control of Cost-Effectiveness Analysis”
   Speaker: Ms. Emiko Yoshida, Representative Director, Healthcare to All Co., Ltd.

“HTA in Japan, it is not only about pricing (hopefully!)…”
   Speaker: Mr. Bruno Rossi, Owner, Satoru G.K.

“Japan's New Approach and Future Challenges on Economic Evaluation of Pharmaceuticals”
   Speaker: Prof. Isao Kamae, Graduate School of Public Policy, Univ. of Tokyo 

2019 Dec. 11 “Recalcitrant Cancers, Rare Cancers and PPI”
  Mr. Yoshiyuki Majima, Chairperson, NPO PanCAN Japan     
2020 Jan. 15 “M3’s Aspiration: Patient Centric Healthcare Productivity Maximization.”
  Ms. Anna Kiso, Head of Investor Relations, 7P Group Executive Officer, SPBU Global Projects
  Director, M3 Inc.
2020 Feb. 19 “Japan Pharma Market Perspectives 2020 - Outlook to 2024”
  Mr. Alan Thomas, Director, Thought Leadership, IQVIA Solutions Japan K.K.

*Canceled to prevent the spread of COVID-19.
   Mar. 18, 2020
   Apr. 15, 2020
   May. 20, 2020

JA